Partner organizations

ADMA BioCenters Plasma Collection Facility coming to Knoxville, TN

ADMA Biologics press release announces FDA approval for new Plasma Center.

American Plasma Users Coalition

Plasma Hero joins national patient organizations created to address the unique needs of patients with rare diseases who use lifesaving plasma protein therapies.

FDA proposes risk-based rules for plasma and blood donations

On January 27, 2023, the U.S. Food and Drug Administration announced a draft proposal for eligibility rules for blood and blood product donation using “gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV.”

GBS, CIDP, and plasma

Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are rare neurological disorders and plasma-based therapies are used to treat them.

Science-based policies boost plasma donation globally

Science is driving global advancements in policy and allowing more people around the world to donate plasma while ensuring the safety of donors and the plasma collected.

Partner organizations

ADMA BioCenters Plasma Collection Facility coming to Knoxville, TN

American Plasma Users Coalition

FDA proposes risk-based rules for plasma and blood donations

GBS, CIDP, and plasma

Science-based policies boost plasma donation globally

Categories

Follow Us

Sitemap